In collaboration with the American College of Cardiology (ACC), Acarix , a developer of acoustic and AI-based cardiac diagnostics based in Sweden, has released a first edition of a framework for the CADScor System. The framework offers a workflow for the CADScor System as a diagnostic aid in patients with stable chest pain.
New onset stable chest pain is a common problem in the United States. Distinguishing between serious and benign chest pain is imperative to appropriately stratify patients to determine their best course of care. Risk stratification can be challenging, especially in care settings with limited cardiology resources, lack of access to diagnostic testing, or high patient volumes that result in extended wait times for assessment.
The ACC recognizes the challenges of risk stratification in patients with chest pain and collaborated with Acarix to assess the utility and role of the CADScor System. Through this collaboration, a framework has been developed for the proposed use of the CADScor System as an early diagnostic aid in the assessment of chest pain.
“As novel diagnostic technologies emerge, the ACC, through its Innovation Program, is focused on collaborating with companies to develop workflows and usability frameworks early in development to facilitate implementation of these technologies in our healthcare systems,” says Ami Bhatt, MD, FACC, ACC chief innovation officer.
“We appreciate the opportunity to collaborate with the ACC on the development of the CADScor System framework,” says Helen Ljungdahl Round, Acarix president and CEO. “Together, we are paving the way for a new, innovative diagnostic solution and providing a rapid response, powered by our unique acoustic and AI-based technology.”